您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (1): 94-96.doi: 10.6040/j.issn.1671-7554.0.2015.693

• 临床医学 • 上一篇    

同时性原发性乳腺癌合并原发性双侧卵巢癌1例

徐志宏1,姚铁柱2,吴小华3   

  1. 1.河北医科大学第四医院肿瘤内科, 河北 石家庄 050011;
    2.河北医科大学第四医院心内科, 河北 石家庄 050011;
    3. 白求恩国际和平医院妇产科, 河北 石家庄 050000
  • 收稿日期:2015-07-22 出版日期:2016-01-11 发布日期:2016-01-11
  • 通讯作者: 徐志宏. E-mail:13933859349@163.com E-mail:13933859349@163.com

  • Received:2015-07-22 Online:2016-01-11 Published:2016-01-11

关键词: 乳腺癌, 卵巢癌, 原发性, 同时性

中图分类号: 

  • R737
[1] Koyama T, Mikami Y, Saga T, et al. Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation[J]. Abdom Imaging, 2007, 32(6):784-795.
[2] Chen S, Paruligiani G. Meta—analysis of BRCAl and BRCA2 penetrance[J]. J Clin Oneol, 2007, 25(11):1329-1333.
[3] Vollebergh MA, Lips EH, Nederlof PM, et al. Genomic patterns resembling BRCAl-and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy[J]. Breast Cancer Res, 2014, 16(3):R47.
[4] Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCAl or BRCA2 mutations detected in case series unselected for family history: a combined analysis of22 studies[J]. Am J Hum Genet, 2003, 72(5):1117- 1130.
[5] 李向东.C-erbB-2、ER和PR在乳腺癌中的表达与预后意义[J].现代肿瘤医学,2006,14(3):289. LI Xiangdong. Expression and prognostic significance of C-erbB-2, ER and PR in breast cancer[J]. Modern Oncology Medicine, 2006, 14(3):289.
[6] Verma S, Joy AA, Rayson D, et al. HER story: the next chapter in HER-2-directed therapy for advanced breast cancer[J]. Oncologist, 2013, 18(11):1153-1166.
[7] Giordano SH, Temin S, Kirshner JJ, et al. Systemic therapy for patients with advanced human epidermal growth factor receptor2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline[J]. J Clin Oncol, 2014, 32(19):2078-2099.
[8] Verri E, Guglielmini P, Puntoni M, et al. NER2/neu oncoprotein overexpression in epitheliaI ovarian cancer: evaluation of its prevalence and prognosticsignificance[J]. Oncology, 2005, 68:154-161.
[9] 何以丰,徐丛剑,冯令达.HER2与上皮性卵巢癌术后生存率相关性的Meta分析[J].中国循证医学杂志,2007,7(6):420. HE Yifeng, XU Congjian, FENG Lingda. Meta analysis of the correlation between HER2 and the survival rate of epithelial ovarian cancer[J]. Chinese Journal of Evidence-based Medicine, 2007, 7(6):420.
[10] Camilleri-Broet S, Hardy-Bessard AC, Le Tourneau A, et al. HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group[J]. Ann Oncol, 2004, 15(1):104.
[11] Riener EK, Arnold N, Kommoss F, et al. The prognostic and predictive valw of immunohistochemically detected,Her-2 overexpression in 361 patients with ovarian cancer;a multicenter study[J]. Gynecol Oncol, 2004, 95(1):89.
[12] Wolff EF, Martel M, Gwin K, et al. Synchronous primary breast and ovarian cancer with ovarian cancer metastases to a breast sentinel lymph node[J]. Breast J, 2009, 15(2):203-205.
[13] Sandor V, Reed E, Sarosy G, et al. Synchronous inflammatory breast cancer and advanced ovarian carcinoma: a case with prolonged disease—free survival[J]. Ann Oncol, 1999, 10(5): 585-588.
[14] Lesnock JL, Darcy KM, Tian C, et al. BRCAl expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a gynecologic oncology group study[J]. Br J Cancer, 2013, 108(6):1231-1237.
[1] 徐加龙,孙小刚,王军锋,刘倩,马楠,李殿国,陈维秀,李金良,王若义. 经腹腔镜手术与开放手术治疗原发性膀胱憩室临床效果比较[J]. 山东大学学报(医学版), 2017, 55(7): 95-99.
[2] 李睿,马伟红,任满意,赵萌萌,姜珊,巨媛媛,郭颖,孙昭辉,隋树建. TWEAK与原发性高血压患者心脏重塑的相关性[J]. 山东大学学报(医学版), 2017, 55(5): 49-55.
[3] 李雁翔,张温花,杨飞龙,方量,徐忠华. 尿路上皮癌BRCA1基因与蛋白表达的相关性[J]. 山东大学学报(医学版), 2017, 55(5): 91-94.
[4] 廉开礼,李炎,张娜,靳桂媛,刘素侠. TIPE3上调P-gp表达降低乳腺癌细胞对阿霉素的敏感性[J]. 山东大学学报(医学版), 2017, 55(5): 36-42.
[5] 彭岳,冯振,谢厚耐,王晖,李猛,任万刚,刘通,彭忠民. 61例肺部多发病灶患者的外科治疗[J]. 山东大学学报(医学版), 2017, 55(11): 42-46.
[6] 陆衡,刘延国,李曙光,陈晓康,田琦,衣翠华,王秀问. YKL-40对卵巢癌SKOV-3细胞迁移能力的影响[J]. 山东大学学报(医学版), 2017, 55(1): 33-38.
[7] 刘相永,孙颖,黎莉. PARP-1抑制剂对BRCA1基因沉默的乳腺癌细胞株MCF-7及PTEN基因沉默的前列腺癌细胞株22RV1增殖的影响[J]. 山东大学学报(医学版), 2016, 54(5): 6-11.
[8] 徐志宏,刘荣凤,王晓翔,冯莉,姚铁柱,刘红. 养正消积胶囊联合化疗治疗转移性乳腺癌的临床疗效及安全性[J]. 山东大学学报(医学版), 2016, 54(5): 79-83.
[9] 王丹,亓恒涛,孙书珍. 原发性肾病综合征儿童颈动脉结构和功能改变[J]. 山东大学学报(医学版), 2016, 54(5): 88-91.
[10] 赵云霞,宋静,张灿灿,林雪艳,尉蔚,田永杰. CXXC4增强上皮性卵巢癌细胞对化疗药物的敏感性[J]. 山东大学学报(医学版), 2016, 54(3): 24-29.
[11] 徐志宏,吴小华,姚铁柱,王晓翔,段晓阳,史健. mir-99a的表达与上皮性卵巢癌患者预后的关系[J]. 山东大学学报(医学版), 2016, 54(3): 77-80.
[12] 马新军. 原发性皮肤腺样囊性癌1例[J]. 山东大学学报(医学版), 2016, 54(12): 95-96.
[13] 李靖华, 李伟华. 乳腺纤维瘤与乳腺癌的超声鉴别诊断[J]. 山东大学学报(医学版), 2014, 52(Z1): 142-143.
[14] 彭静, 李卉, 杜玮. 皮下注射硼替佐米的护理体会[J]. 山东大学学报(医学版), 2014, 52(Z1): 180-181.
[15] 江洪, 刘洪, 黄彩英, 梁烨, 李近都, 卢冠铭, 李天资. 原发性高血压患者miRNA-375表达变化的临床意义[J]. 山东大学学报(医学版), 2014, 52(S2): 9-10.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!